User login
In the October podcast for The Journal of Community and Supportive Oncology, the Editor-in-Chief, Dr David Henry, discusses Original Reports on toxicity analysis of docetaxel, cisplatin, and 5-fluorouracil neoadjuvant chemotherapy in Indian patients with head and neck cancers and on the impact of a literacy-sensitive intervention on CRC screening knowledge, attitudes, and intention to screen as well as an editorial by JCSO Editor Jame Abraham on lessons learned from using CDK 4/6 inhibitors to treat metastatic breast cancer. Also up for discussion are the approval of cabozantinib for renal cell carcinoma, and two Case Reports on central nervous system manifestations of multiple myeloma and on primary chest-wall leiomyosarcoma. Rounding out the discussion are two featured articles, one on new therapies for urologic cancers and another on a step-by-step guide for doctors who want to take to the Twittersphere.
Listen to the podcast below.
In the October podcast for The Journal of Community and Supportive Oncology, the Editor-in-Chief, Dr David Henry, discusses Original Reports on toxicity analysis of docetaxel, cisplatin, and 5-fluorouracil neoadjuvant chemotherapy in Indian patients with head and neck cancers and on the impact of a literacy-sensitive intervention on CRC screening knowledge, attitudes, and intention to screen as well as an editorial by JCSO Editor Jame Abraham on lessons learned from using CDK 4/6 inhibitors to treat metastatic breast cancer. Also up for discussion are the approval of cabozantinib for renal cell carcinoma, and two Case Reports on central nervous system manifestations of multiple myeloma and on primary chest-wall leiomyosarcoma. Rounding out the discussion are two featured articles, one on new therapies for urologic cancers and another on a step-by-step guide for doctors who want to take to the Twittersphere.
Listen to the podcast below.
In the October podcast for The Journal of Community and Supportive Oncology, the Editor-in-Chief, Dr David Henry, discusses Original Reports on toxicity analysis of docetaxel, cisplatin, and 5-fluorouracil neoadjuvant chemotherapy in Indian patients with head and neck cancers and on the impact of a literacy-sensitive intervention on CRC screening knowledge, attitudes, and intention to screen as well as an editorial by JCSO Editor Jame Abraham on lessons learned from using CDK 4/6 inhibitors to treat metastatic breast cancer. Also up for discussion are the approval of cabozantinib for renal cell carcinoma, and two Case Reports on central nervous system manifestations of multiple myeloma and on primary chest-wall leiomyosarcoma. Rounding out the discussion are two featured articles, one on new therapies for urologic cancers and another on a step-by-step guide for doctors who want to take to the Twittersphere.
Listen to the podcast below.